Epigenetic Reprogramming of Monocytes in Patients With Coronary Atherosclerosis

NCT02393768 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2016-04-22

No results posted yet for this study

Summary

In this study, the investigators will determine whether patients with documented atherosclerosis are characterized by specific epigenetic changes in circulating cells of the innate immune system, compared to patients without atherosclerosis.

Conditions

Sponsors & Collaborators

  • Canisius-Wilhelmina Hospital

    collaborator OTHER
  • Radboud University Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-10-31
Completion
2015-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02393768 on ClinicalTrials.gov